25 Comments

the difference in expected and observed mortality is astounding, great catch. it will be fascinating to see the full documentation (if they ever stop extending the trial duration).

Expand full comment
Mar 24, 2023Liked by OpenVAET

“there aren’t enough deaths documented here.”

Thank you. I have made this same point before, but it cant seem to be grasped by otherwise very smart people.

This is either the healthiest people in the world, or the tracking system is faulty. If the former, the results in no way reflect on the vaccines safety in the real world. If the latter, the trial is garbage.

Expand full comment
Apr 11, 2023Liked by OpenVAET

I would have hoped for a "Healthy User Bias" in this trial. The case of the rapid dementia death (10891088) is the most egregious. Most of the dementia patients I have seen over four decades of general practice have progressed over some years.

Steve Kirsch's Substack today also makes the point that inadequate information on cause of death is almost universal since the introduction of the Covid pandemic. Without specific Spike stains we cannot tell if the dead were infected with Covid or injected with spike mRNA or both. For bonus points it would be handy to look for evidence of circulating mRNA as well, even up to a PCR cycle threshold of 30.

I am impressed with your analysis of the "missing" deaths in this trial. In my experience, practising physicians have little intuitive insight into actuarial mortality, and are easily convinced by presentation of "Relative Risk Reduction."

Expand full comment

The problem with the high death rate in the placebo group is that it appears that there actually WAS NO PLACEBO.

Hospira's saline solution (used by Pfizer) ALSO contains nanotechnology:

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-sterile-water-injection-usp-due-potential

https://www.researchgate.net/publication/309756855_Microparticles_and_Nanoparticles_Delivered_in_Intravenous_Saline_and_in_an_Intravenous_Solution_of_a_Therapeutic_Antibody_Product

Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product

IV saline in bags manufactured by both Hospira and Baxter contained 1600-8000 microparticles/mL and 4-73 × 10⁶ nanoparticles/mL in solution.

https://www.ashp.org/news/2015/01/23/hospira-recalls-two-injectable-products?loginreturnUrl=SSOCheckOnly

Hospira this week announced the recall of one lot of sodium chloride injection and dozens of lots of etorolac tromethamine injection after receiving reports of particulate matter in the product containers.

Expand full comment
deletedMar 24, 2023Liked by OpenVAET
Comment deleted
Expand full comment